Literature DB >> 12773277

Electroconvulsive therapy in the medically ill.

Eric J Christopher1.   

Abstract

The use of electroconvulsive therapy (ECT) in the US continues to expand in the treatment of psychiatric disorders. Electroconvulsive therapy remains the "gold standard" for the treatment of major depression and a variety of other psychiatric and neurologic disorders. Because of the effectiveness and resurgence of ECT, more patients are considered good candidates for this treatment option. Overall, these patients are medication refractory and elderly, and thus more sensitive to polypharmacy. Additionally, these patients tend to have more coexisting medical problems, and often require that a practitioner have solid clinical knowledge of the fields of medicine and psychiatry. This article will review some of the most common comorbid conditions found in patients referred for ECT.

Entities:  

Mesh:

Year:  2003        PMID: 12773277     DOI: 10.1007/s11920-003-0047-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  51 in total

1.  Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity.

Authors:  Zen'ichiro Wajima; Tatsusuke Yoshikawa; Akira Ogura; Kazuyuki Imanaga; Toshiya Shiga; Tetsuo Inoue; Ryo Ogawa
Journal:  Anesth Analg       Date:  2002-08       Impact factor: 5.108

2.  Postictal neurogenic pulmonary edema: experience from an ECT model.

Authors:  S L Wayne; C A O'Donovan; W V McCall; K Link
Journal:  Convuls Ther       Date:  1997-09

3.  Effects of electroconvulsive therapy on cardiac function in patients without heart disease.

Authors:  A J Fuenmayor; Y el Fakih; J Moreno; A M Fuenmayor
Journal:  Cardiology       Date:  1997 May-Jun       Impact factor: 1.869

4.  ECT and automatic internal cardioverter-defibrillator.

Authors:  M I Lapid; T A Rummans; V E Hofmann; B A Olney
Journal:  J ECT       Date:  2001-06       Impact factor: 3.635

5.  EST in a patient with idiopathic thrombocytopenic purpura.

Authors:  S H Kardener
Journal:  Dis Nerv Syst       Date:  1968-07

6.  Asystole in electroconvulsive therapy: Report of four cases.

Authors:  W V McCall
Journal:  J Clin Psychiatry       Date:  1996-05       Impact factor: 4.384

7.  Cardiovascular complications of ECT.

Authors:  A Stoudemire
Journal:  Am J Psychiatry       Date:  1994-05       Impact factor: 18.112

8.  Lowered insulin requirements after ECT.

Authors:  P S Normand; M A Jenike
Journal:  Psychosomatics       Date:  1984-05       Impact factor: 2.386

9.  Incidence of asystole in electroconvulsive therapy in elderly patients.

Authors:  J Burd; P Kettl
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

10.  Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy.

Authors:  I Castelli; L A Steiner; M A Kaufmann; P H Alfillé; R Schouten; C A Welch; L J Drop
Journal:  Anesth Analg       Date:  1995-03       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.